Richard Nolan Townsend - Chief Executive Officer, Director at Lexeo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
LXEO on Nasdaq
All Insider Reports
All Insider Reports

Richard Nolan Townsend - trading volume in the past year for Lexeo Therapeutics, Inc.

Holdings reported by Richard Nolan Townsend for Lexeo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 392,483 $2,504,826 $6.38 18 Feb 2026 Direct
Stock Option (right to buy) 646,665 04 Feb 2026 Direct Common Stock

Transactions reported by Richard Nolan Townsend for Lexeo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.